Fig. 1From: Quantification of intratumoral heterogeneity using habitat-based MRI radiomics to identify HER2-positive, -low and -zero breast cancers: a multicenter studyFlowchart of patient inclusion and exclusion criteria in the study. HER2, human epidermal growth factor receptor 2Back to article page